- Received November 30, -0001
- Accepted November 30, -0001
- Publication July 20, 2020
- Visibility 3 Views
- Downloads 0 Downloads
- DOI 10.18231/j.ijn.2020.020
-
CrossMark
- Citation
Relationship of Serum Vitamin D levels with Nerve Conduction Velocity in patients of Diabetic Neuropathy
- Author Details:
-
Saquib Alam
-
Kafil Akhtar *
-
Syed A Abbas
-
Sheelu S Siddiqui
-
Shagufta Moin
Introduction
Diabetes mellitus is known as a group of common metabolic disorders, mainly a condition that has presence of a chronic hyperglycemia with disturbances of carbohydrate, fat and protein metabolism associated absolute or relative insulin deficiencies in their secretions and action.[1]
Diabetes is one of the most important leading cause of blindness (retinopathy), end stage renal disease and a variety of debilitating neuropathies.[2] Diabetic neuropathy is the most common complication diabetes mellitus and also the major leading cause of morbidity and mortality in diabetic patients.[3] There have been recent speculations that circulating 25-hydroxyvitamin D (25(OH)-D) could be involved in the Diabetic neuropathy development and its progression.[4], [5]
A very important role is played by vitamin D in metabolic disease, like diabetes mellitus. It appears that lower level of vitamin D is mainly related to neuropathy development and predisposes to many other neurodegenerative disorders, suggesting that treatment with vitamin D can lead to correction of these predisposing metabolic disturbances in the body.[6] We intend to highlight the relationship of serum Vitamin D levels with Nerve Conduction Velocity (NCV) in patients of Diabetic Neuropathy in the present study.
Materials and Methods
This prospective study was conducted on 52 patients with Diabetic Neuropathy, after approval from ethical committee of the college and taking written informed consent from the patients. The baseline characteristics were compared between age and sex matched type 2 diabetic patients having peripheral neuropathy with healthy controls.
A detailed history and thorough physical examination was carried out on every case in the study as per a pre-designed proforma. Selected cases of Type 2 Diabetes Mellitus patients were assessed for diabetic peripheral neuropathy by both sensory and motor nerve conduction velocity(Apparatus:NeuroStim4-NS4 EMG/NCV/EP SYSTEM, Medicaid, India).Selected patients were assessed with neuropathy symptom score (NSS) with symptoms of paresthesias like burning/numbness/tingling/cramping/aching and clinical examination for neuropathy disability score (NDS). Blood samples were collected in EDTA vials for estimation of HbA1C, Sodium Fluoride vials for plasma glucose, in plain vial for serum Vitamin D by the “LIAISON DiaSorin 25-OH Vitamin D assay”. Blood for fasting and post prandial glucose estimation was collected on the same day. All the data was statistically analyzed using SPSS software version (20.0). Statistical analysis was performed by Chi square tests and ANOVA according to the variables and the comparisons needed. p-value of 0.05 or less was considered to be statistically significant.
Observations
Our study included 52 provisionally diagnosed patients of peripheral neuropathy comprising of 27 males and 25 females, who met the inclusion/exclusion criteria and had given valid written consent. A group of 12 normal individuals without diabetes served as control in our study.
The most common symptom was tingling in 20(31.3%) cases, followed by tingling and numbness in 14(21.9%) burning sensation and tingling in 6(9.4%) and weakness of limbs and cramping in 5(7.8%) patients.
Majority of the patients showed decrease in SNCV in more than three nerves; 17(32.69%), followed by three nerves in 13(25.0%) patients ([Table 1]). Majority of the patients showed decrease in MNCV in more than 3 three nerves; 15(28.84%), followed by three nerve involvement in 13(25.0%) patients ([Table 2] ).
Thirty six (69.2%) of the diabetic patients were deficient in vitamin D, followed by vitamin D insufficiency in 14(26.9%) (p value<0.001). Among the vitamin D deficient patients, females were in excess of males, (52.8%), (p value=0.314) ([Table 3]). The vitamin D deficiency increased in proportion to the duration of disease, with maximum number of vitamin D deficient patients in the disease duration of 11-15 years followed by vitamin D deficient patients with duration of disease>15 years ([Table 4]).
Majority of the vitamin D deficient patients had higher levels of HbA1c, with 14(87.5%) patients having HbA1c levels >11.5. Vitamin D deficiency was more pronounced than insufficiency as the HbA1c levels got increased ([Table 5], [Table 6]).
| Observations | Number of patients | Percentage |
| No impact-normal SNCV | 03 | 05.8 |
| Decrease in SNCV of one nerve | 10 | 19.2 |
| Decrease in SNCV of two nerves | 09 | 17.3 |
| Decrease in SNCV of three nerves | 13 | 25.0 |
| Decrease in SNCV of > 3 nerves | 17 | 32.7 |
| Total | 52 | 100.0 |
| Observations | Number of patients | Percentage |
| No impact-normal MNCV | 04 | 7.7 |
| Decrease in MNCV of one nerve | 08 | 15.4 |
| Decrease in MNCV of two nerves | 12 | 23.1 |
| Decrease in MNCV of three nerves | 13 | 25.0 |
| Decrease in MNCV of ≥ 3 nerves | 15 | 28.8 |
| Total | 52 | 100.0 |
| Vitamin D levels | Male | Female | Total | Chi square value=32.842 p<0.001 | ||
| No. | % | No. | % | No. | % | |
| Deficiency | 17 | 47.2 | 19 | 52.8 | 36 | 69.2 |
| Insufficiency | 10 | 71.5 | 04 | 28.5 | 14 | 26.9 |
| Sufficiency | 02 | 100.0 | 00 | 00 | 02 | 03.8 |
| Total | 29 | 55.8 | 23 | 44.2 | 52 | 100.0 |
| Duration of diabetes (years) | Number of patients with vitamin D levels | ||
| Deficiency | Insufficiency | Sufficiency | |
| 0-5 | 02 | 02 | 00 |
| 6-10 | 09 | 04 | 00 |
| 11-15 | 14 | 02 | 02 |
| >15 | 12 | 05 | 00 |
| Total | 37 | 13 | 02 |
| HbA1c levels (%) | Number of patients with different vitamin D levels | |||||||
| Deficiency | Insufficiency | Sufficiency | Total | |||||
| No. | % | No. | % | No. | % | No. | % | |
| 6.6-7.5 | 00.0 | 00 | 03 | 100 | 00.0 | 00.0 | 03 | 05.7 |
| 7.6-8.5 | 05 | 62.5 | 03 | 37.5 | 00.0 | 00.0 | 08 | 15.4 |
| 8.6-9.5 | 09 | 69.3 | 03 | 23.0 | 01 | 07.7 | 13 | 25.0 |
| 9.6-10.5 | 04 | 57.2 | 02 | 28.6 | 01 | 14.2 | 07 | 13.5 |
| 10.6-11.5 | 05 | 83.4 | 01 | 16.6 | 00.0 | 00.0 | 06 | 11.5 |
| >11.5 | 13 | 86.7 | 02 | 13.3 | 00.0 | 00.0 | 15 | 28.9 |
| Total | 36 | 69.2 | 14 | 26.9 | 02 | 03.8 | 52 | 100.0 |
| Variable | Controls (n=12) | Diabetic subjects (n=52) | P value | |
| Number | Male | 7 | 27 | 0.689 |
| Female | 5 | 25 | ||
| Age (years) | 55.17±13.11 | 56.42± 11.58 | 0.743 | |
| Duration of T2DM(years) | 0 | 12.90± 5.02 | ||
| Fasting plasma Glucose (mg/dl) | 93±10.67 | 167.02±25.87 | <0.0001 | |
| Post prandial glucose (mg/dl) | 119.75±15.43 | 223.18±50.72 | <0.0001 | |
| HbA1c (%) | 5.54±0.36 | 10.50±2.21 | <0.0001 | |
| Vitamin D (ng/dl) | 42.49±6.99 | 17.22±6.82 | <0.0001 | |
| Right sided SNCV(m/s) of | Sural nerve | 49.6±1.2 | 42.1±4.2 | <0.0001 |
| Median nerve | 52.7±1 | 46.3±6.5 | 0.0013 | |
| Ulnar nerve | 51.5±1 | 48.4±4.8 | 0.0306 | |
| Left sided SNCV(m/s) of | Sural nerve | 49.8±1 | 41.8±4.2 | <0.0001 |
| Median nerve | 52.3±1 | 47.6±5.7 | 0.0063 | |
| Ulnar nerve | 52.2±1.5 | 48.3±4.8 | 0.0074 | |
| Right sided MNCV(m/s) of | Common Peroneal Nerve | 48.9±2 | 42.5±3.4 | <0.0001 |
| Posterior Tibial Nerve | 48.8±1.5 | 42.7±3.5 | <0.0001 | |
| Median nerve | 55.9±1 | 49.2±7.8 | 0.0045 | |
| Left sided MNCV(m/s) of | CPN | 48.2±1.8 | 42.7±3.3 | <0.0001 |
| PTN | 48.5±1.3 | 44.1±1.6 | <0.0001 | |
| Median nerve | 55.2±1 | 51.8±2.9 | 0.0002 |
Discussions
The most common symptom was tingling in 20(31.3%) cases, followed by tingling and numbness in 14(21.9%) burning sensation and tingling in 6(9.4%) and weakness of limbs and cramping in 5(7.8%) patients. Similar symptoms were shown in the study by Pop-Busui et al.[2]
The age range of type 2 diabetic patients with neuropathy was between 30-77 years old with average of 56.4±11.6 years. Similar results were shown by study done by Popescu et al who reported a median age of the diabetic patients as 62 years.[3] In our study, we found the prevalence of diabetic peripheral neuropathy to be 32.2%. Tesfaye et al, Pradeepa et al and Gill et al have stated a prevalence of 28.0%, 26.1% and 29.4% respectively.[4], [5], [6]
With increasing age of diabetic patients, the incidence of diabetic complications of peripheral neuropathy increased. In our study the number of patients of diabetic peripheral neuropathy increased with age from 11.5% in the age group of 31-40 years old to 38.5% in the age group of >60 years old. Our finding was consistent with Morkrid et al who reported the prevalence of diabetic neuropathy as 11.1% in the 23-40 years old age-group and 32.3% between 60-80 years.[7] Similar results have also been reported in the study by Zoungas et al.[8]
Twenty seven (51.9%) cases were males and 25(48.1%) were females with a male to female ratio of 1:08 in our study. So, the gender-wise distribution of cases did not show any significant difference.
We found that the duration of diabetes mellitus played an important role on the development of diabetic neuropathy. Majority of the diabetic patients with neuropathy had duration of the disease of more than 10 years, 34(65.4%) patients followed by 14(26.9%) patients with 6-10 years of duration of diabetes. Similar results have been reported by Deshpande et al.[9]
The glycemic status of the type 2 diabetic mellitus patients with neuropathy was higher in most of the patients, 28.9% patients had HbA1c level >11.5% with the major gender being females, comprising 53.4% cases. Also, as the duration of the disease increased, the HbA1c levels got increased in our patients which subsequently lead to diabetic neuropathy. So, a long duration of diabetes and poor glycemic control leads to increased occurrence of diabetic neuropathy. Oguejiofor et al found a lower prevalence of polyneuropathy with duration of diabetes mellitus <5 years and high prevalence with a duration of diabetes mellitus >15 years.[10] Similar findings were also shown by Nisaret al in their study.[11]
For assessing diabetic peripheral neuropathy, sensory and motor nerve conduction velocities of peripheral nerves were done, both in upper and lower limbs. It is considered as a gold standard for diagnosis of neuropathy.[12] In our study, we assessed nerve conduction velocities of 6 pairs of peripheral nerves comprising of 3 pairs of sensory nerves and 3 pairs of motor nerves. We found statistically significant decrease in nerve conduction velocities of all the nerves assessed in the cases of neuropathy as compared to the controls (p value˂ 0.05). A study by Tehrani et al showed similar results.[13]
We found that the numbers of peripheral nerve involvement was more as the duration of diabetes mellitus increased from 7.7% in 1-5 years to 32.7% in 11-15 years duration. The association between the duration of diabetes mellitus and neuropathy was also evident in several research studies by Nisar et al and Maser et al on the epidemiology of diabetic complications. [11], [14]
There was early involvement of sensory nerves as compared to motor nerves in patients of diabetic neuropathy. This finding is consistent with the reports of Halar et al and Nascimento et al. [15], [16] We also found that there was involvement of only the sural nerve in many patients, which was also the earliest and most common nerve to be affected. Similar findings have been reported in studies by Riihimaa et al and Karsidag et al. [17], [18]
An association between vitamin D deficiency and prevalence of type 2 diabetes mellitus with neuropathy was seen; 69.3% of our patients were deficient in vitamin D. Similar results were shown by Qu et al. [19] Also, we found that the level of vitamin D was lower in patients with longer duration of type 2 diabetes mellitus. Penckofer et al also suggested that there is decrease in vitamin D status as the duration of type 2 diabetes mellitus increases. [20] The vitamin D deficiency was more in females, constituting 19(52.8%) cases. Similar results have been shown in a study by Bayani et al. [21]
We found that most of the patients who were deficient in vitamin D had higher levels of HbA1c levels. Among 36(69.3%) patients who were deficient in vitamin D (i.e vitamin D <50 nmol/l), 13(36.2%) had HbA1c levels >11.5%. This showed a negatively significant coefficient of correlation between vitamin D levels and HbA1c levels which means vitamin D levels showed independent inverse association with HbA1c levels. Similar results have been shown by Buhary et al who reported 73.1% of patients with vitamin D levels< 50 nmol/l with mean HbA1c value of 10.55±2.58%. [22] Dalgard et al, Ghavamzadeh et al and Zhang et al have demonstrated that patients of type 2 diabetes mellitus with hypovitaminosis D are more likely to have raised HbA1c levels. [23], [24], [25]
Conclusions
As the detection of the various dormant signs of diabetic neuropathy at the earliest could minimize the damaging effects and improve the quality of life; it is recommended that nerve conduction velocity test should be performed on all diabetic patients routinely. Also screening of such patients is very essential with monitoring of HbA1c and serum vitamin D. Vitamin D deficiency might be independently associated with peripheral neuropathy in type 2 diabetes mellitus, so investigative parameters like Vitamin D could be used as an independent marker to assess the severity of diabetic neuropathy.
Source of Funding
None.
Conflict of Interest
None.
References
- Ambady Ramachandran, Chamukuttan Snehalatha. Current scenario of diabetes in India. J Diabetes 2009. [Google Scholar]
- Rodica Pop-Busui, Andrew J.M. Boulton, Eva L. Feldman, Vera Bril, Roy Freeman, Rayaz A. Malik. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017. [Google Scholar]
- Flavia Baderca, Bogdan Timar, Simona Popescu, Mihaela Simu, Laura Diaconu, Iulian Velea. Age as an independent factor for the development of neuropathy in diabetic patients. Clin Interv Aging 2016. [Google Scholar]
- S. Tesfaye, L. K. Stevens, J. M. Stephenson, J. H. Fuller, M. Plater, C. Ionescu-Tirgoviste. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996. [Google Scholar]
- R. Pradeepa, M. Rema, J. Vignesh, M. Deepa, R. Deepa, V. Mohan. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabetic Med 2008. [Google Scholar]
- SB Yadav, V Ramesh, E Bhatia, HK Gill. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med 2014. [Google Scholar]
- K Morkrid, L Ali, A Hussain. Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabeteic outpatients in Bangladesh. Int J Diabetes Dev Ctries 2010. [Google Scholar]
- Sophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diab Endocrinol 2017. [Google Scholar]
- Anjali D Deshpande, Marcie Harris-Hayes, Mario Schootman. Epidemiology of Diabetes and Diabetes-Related Complications. Phys Ther 2008. [Google Scholar]
- O C Ogueijiofor, C Odenigbo, C B Oguejiofor. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry. Niger J Clin Pract 2010. [Google Scholar]
- Muhammad Umer Nisar, Ambreen Asad, Ahmed Waqas, Nazia Ali, Anam Nisar, Mohsin A Qayyum. Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control. Cureus 2015. [Google Scholar]
- . American Diabetes Association. Standardised measures in diabetic neuropathy. Diab Care 1996. [Google Scholar]
- Khn Tehrani. A study of nerve conduction velocity in diabetic patients and its relationship with tendon reflexes. Maced J Med Sci 2018. [Google Scholar]
- R E Maser, M A Pfeifer, J S Dorman, L H Kuller, D J Becker, T J Orchard. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990. [Google Scholar]
- E M Halar, R J Graf, J B Haltar, F V Brozovick, B T Soine. Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study. Arch Phys Med Rehabil 1982. [Google Scholar]
- Osvaldo José Moreira do Nascimento, Camila Castelo Branco Pupe, Eduardo Boiteux Uchôa Cavalcanti. Diabetic neuropathy. Rev Dor 2016. [Google Scholar]
- P. H. Riihimaa, K. Suominen, U. Tolonen, V. Jantti, M. Knip, P. Tapanainen. Peripheral Nerve Function Is Increasingly Impaired During Puberty in Adolescents With Type 1 Diabetes. Diabetes Care 2001. [Google Scholar]
- S. Karsidag, S. Moralı, M. Sargın, S. Salman, K. Karsidag, O. Us. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diab Res Clin Prac 2005. [Google Scholar]
- G B Qu, L L Wang, X Tang, W Wu, Y H Sun. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: An update systemic review and meta-analysis. J Clin Transl Endocrinol 2017. [Google Scholar]
- Sue Penckofer, JoAnne Kouba, Diane E. Wallis, Mary Ann Emanuele. Vitamin D and Diabetes. Diab Educ 2008. [Google Scholar]
- M A Bayani, R Akbari, F Saeedi. Status of Vitamin D in diabetic patients. Caspian J Intern Med 2014. [Google Scholar]
- Badurudeen Mahmood Buhary, Ohoud Almohareb, Naji Aljohani, Saleh Alrajhi, Samer Elkaissi, Suphia Sherbeeni. Association of Glycosylated Hemoglobin Levels With Vitamin D Status. J Clin Med Res 2017. [Google Scholar]
- C. Dalgard, M. S. Petersen, P. Weihe, P. Grandjean. Vitamin D Status in Relation to Glucose Metabolism and Type 2 Diabetes in Septuagenarians. Diabetes Care 2011. [Google Scholar]
- S Ghavamzadeh, M Mobasseri, R Mahdavi. The effect of Vitamin D Supplementation on adiposity, Blood Glycated Hemoglobin, Serum Leptin and Tumor Necrosis Factor-α in Type 2 Diabetic Patients. Int J Prev Med 2014. [Google Scholar]
- J P Zhang, N Xu, D Yin, Y Hui, N Ma, G J Han. Association between the level of serum vitamin D and peripheral neuropathy in type 2 diabetic patients. Chin J Endocrinol Metab 2014. [Google Scholar]